Zynerba Pharmaceuticals Inc. (ZYNE) rose 5.49% or 0.48 to $9.23. It is close to 188868 shares traded, which is 72.52% compare to the average total volume 260420. The market cap of ZYNE is $125.17 million. The year to date change is -32.67%. The 52 week price range is from $5.42 to $20.73. Price of ZYNE have changed -14.47% during last week. It have changed -9.42% over last month, -23.04% over last 3 months, -27.75% over last 6 months and -54.55% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 9.62. It is 4.23% above current price. The 200-day Moving Averages for ZYNE is 10.20. It is 10.51% above current price. The 52-week High is 20.73. It is 124.59% from the current price. The 52-week Low is 5.42. It is -41.28% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 10.38 on 2018-04-30. Short % to float is 23.82%. There are some statistics of ZYNE. It is has market cap $125.17 million. The share outstanding is 13.56 million. The average volume is 260420. The percent of top 15 Institution holding is 30.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -67.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -57.81%.